文献速递肝病

非酒精性脂肪性肝病患者的肝病无创评估

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Gastroenterology · 2019-01-18

肝活检虽为金标准但存在有创性、抽样变异等局限,本文综述NAFLD肝病无创评估的现状,并提供专家整合意见。

要点

  • NAFLD患者的关键问题:区分NASH与单纯性脂肪变,识别进展期肝纤维化。
  • 肝活检是金标准但有创、有抽样变异、成本高,大规模筛查不实用。
  • 无创评估NASH和纤维化的诊断策略仍需建立成本效益方案。

核心结论

  • 无创评估用于诊断NASH和纤维化是必要的,但建立成本效益筛查策略仍需大量工作。

研究设计与样本

  • 综述,总结NAFLD肝病无创评估的现状并提供专家整合意见。

主要发现

  • 肝活检局限性包括有创性、罕见但可能危及生命的并发症、接受度差、抽样变异和成本。

临床怎么用

  • 作者提供专家整合意见,说明无创工具如何在临床实践中使用。

局限性

  • 建立NASH、进展期纤维化和肝硬化筛查的成本效益策略仍需大量工作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion individuals worldwide. In a subset of NAFLD patients, who have the progressive form of NAFLD termed nonalcoholic steatohepatitis (NASH), it can progress to advanced fibrosis, cirrhosis, hepatocellular carcinoma, and liver-related morbidity and mortality. NASH is typically characterized by a specific pattern on liver histology, including steatosis, lobular inflammation, and ballooning with or without peri-sinusoidal fibrosis. Thus, key issues in NAFLD patients are the differentiation of NASH from simple steatosis and identification of advanced hepatic fibrosis. Until now, liver biopsy has been the gold standard for identifying these 2 critical end points, but has well-known limitations, including invasiveness; rare but potentially life-threatening complications; poor acceptability; sampling variability; and cost. Furthermore, due to the epidemic proportion of individuals with NAFLD worldwide, liver biopsy evaluation is impractical, and noninvasive assessment for the diagnosis of NASH and fibrosis is needed. Although much of the work remains to be done in establishing cost-effective strategies for screening for NASH, advanced fibrosis, and cirrhosis, in this review, we summarize the current state of the noninvasive assessment of liver disease in NAFLD, and we provide an expert synthesis of how these noninvasive tools could be utilized in clinical practice. Finally, we also list the key areas of research priorities in this area to move forward clinical practice.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Castera L, Friedrich-Rust M, Loomba R, et al. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2019. PMID: 30660725. doi:10.1053/j.gastro.2018.12.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。